Submitted by Anonymous (not verified) on 28 September 2023 - 15:41
Opinion/decision on a Paediatric investigation plan (PIP): Clazakizumab, decision type: , therapeutic area: , PIP number: P/0393/2022
Source:
Opinion/decision on a Paediatric investigation plan (PIP): Clazakizumab, decision type: , therapeutic area: , PIP number: P/0393/2022